IRIS Accounts Production v25.1.3.33 07430042 Board of Directors 1.12.23 30.11.24 30.11.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074300422023-11-30074300422024-11-30074300422023-12-012024-11-30074300422022-11-30074300422022-12-012023-11-30074300422023-11-3007430042ns15:EnglandWales2023-12-012024-11-3007430042ns14:PoundSterling2023-12-012024-11-3007430042ns10:Director12023-12-012024-11-3007430042ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3007430042ns10:SmallEntities2023-12-012024-11-3007430042ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3007430042ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3007430042ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3007430042ns10:FullAccounts2023-12-012024-11-300743004212023-12-012024-11-3007430042ns10:Director22023-12-012024-11-3007430042ns10:CompanySecretary12023-12-012024-11-3007430042ns10:RegisteredOffice2023-12-012024-11-3007430042ns5:CurrentFinancialInstruments2024-11-3007430042ns5:CurrentFinancialInstruments2023-11-3007430042ns5:ShareCapital2024-11-3007430042ns5:ShareCapital2023-11-3007430042ns5:RetainedEarningsAccumulatedLosses2024-11-3007430042ns5:RetainedEarningsAccumulatedLosses2023-11-3007430042ns5:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3007430042ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-012024-11-3007430042ns5:FurnitureFittings2023-12-012024-11-3007430042ns5:MotorVehicles2023-12-012024-11-3007430042ns5:ComputerEquipment2023-12-012024-11-3007430042ns5:IntangibleAssetsOtherThanGoodwill2023-11-3007430042ns5:IntangibleAssetsOtherThanGoodwill2024-11-3007430042ns5:IntangibleAssetsOtherThanGoodwill2023-11-3007430042ns5:FurnitureFittings2023-11-3007430042ns5:MotorVehicles2023-11-3007430042ns5:ComputerEquipment2023-11-3007430042ns5:FurnitureFittings2024-11-3007430042ns5:MotorVehicles2024-11-3007430042ns5:ComputerEquipment2024-11-3007430042ns5:FurnitureFittings2023-11-3007430042ns5:MotorVehicles2023-11-3007430042ns5:ComputerEquipment2023-11-3007430042ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3007430042ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3007430042ns5:DeferredTaxation2023-11-3007430042ns5:DeferredTaxation2023-12-012024-11-3007430042ns5:DeferredTaxation2024-11-30074300421ns10:Director12023-11-30074300421ns10:Director12022-11-30074300421ns10:Director12023-12-012024-11-30074300421ns10:Director12022-12-012023-11-30074300421ns10:Director12024-11-30074300421ns10:Director12023-11-30
REGISTERED NUMBER: 07430042 (England and Wales)












Unaudited Financial Statements

for the Year Ended 30 November 2024

for

Orr Medical Limited

Orr Medical Limited (Registered number: 07430042)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Orr Medical Limited

Company Information
for the Year Ended 30 November 2024







DIRECTORS: Dr M C Orr
Mrs D Orr





SECRETARY: Dr M C Orr





REGISTERED OFFICE: 48 Cross Keys Drive
Whittle Le Woods
Chorley
Lancashire
PR6 7TF





REGISTERED NUMBER: 07430042 (England and Wales)





ACCOUNTANTS: Xeinadin
Ground Floor
Citygate
Longridge Road
Preston
Lancashire
PR2 5BQ

Orr Medical Limited (Registered number: 07430042)

Balance Sheet
30 November 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 10,173 10,696
Tangible assets 5 29,580 43,562
39,753 54,258

CURRENT ASSETS
Debtors 6 119,488 59,205
Cash at bank 300,659 352,595
420,147 411,800
CREDITORS
Amounts falling due within one year 7 83,988 68,193
NET CURRENT ASSETS 336,159 343,607
TOTAL ASSETS LESS CURRENT
LIABILITIES

375,912

397,865

PROVISIONS FOR LIABILITIES 8 7,061 10,019
NET ASSETS 368,851 387,846

CAPITAL AND RESERVES
Called up share capital 101 101
Retained earnings 368,750 387,745
SHAREHOLDERS' FUNDS 368,851 387,846

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Orr Medical Limited (Registered number: 07430042)

Balance Sheet - continued
30 November 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 14 May 2025 and were signed on its behalf by:





Dr M C Orr - Director


Orr Medical Limited (Registered number: 07430042)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

Orr Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Intangible fixed asset are being amortised evenly over their estimated useful life of twenty five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Motor vehicles - 25% on cost
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Orr Medical Limited (Registered number: 07430042)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 December 2023
and 30 November 2024 11,218
AMORTISATION
At 1 December 2023 522
Charge for year 523
At 30 November 2024 1,045
NET BOOK VALUE
At 30 November 2024 10,173
At 30 November 2023 10,696

Orr Medical Limited (Registered number: 07430042)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 December 2023 6,081 57,035 8,131 71,247
Additions - - 1,679 1,679
At 30 November 2024 6,081 57,035 9,810 72,926
DEPRECIATION
At 1 December 2023 4,069 17,823 5,793 27,685
Charge for year 503 14,259 899 15,661
At 30 November 2024 4,572 32,082 6,692 43,346
NET BOOK VALUE
At 30 November 2024 1,509 24,953 3,118 29,580
At 30 November 2023 2,012 39,212 2,338 43,562

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 41,439 54,498
Other debtors 18,196 -
Directors' current accounts 53,914 -
Prepayments 5,939 4,707
119,488 59,205

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 60,045 42,303
VAT 12,687 15,210
Other creditors 7,439 6,491
Capital On Tap credit card 1,216 563
Directors' current accounts - 1,071
Accrued expenses 2,601 2,555
83,988 68,193

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 7,061 10,019

Orr Medical Limited (Registered number: 07430042)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

8. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 December 2023 10,019
Credit to Income Statement during year (2,958 )
Balance at 30 November 2024 7,061

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 November 2024 and 30 November 2023:

2024 2023
£    £   
Dr M C Orr
Balance outstanding at start of year 1,070 4,110
Amounts advanced 960 960
Amounts repaid (55,945 ) (4,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (53,915 ) 1,070